Frequency of High MELD Score in Cirrhotic Patients undergoing Liver Resection due to Hepatocellular Carcinoma

被引:0
作者
Farooq, Muhammad Omer [1 ]
Ahmed, Niaz
Nadeem, Hassan
Rafi, Kashif
Jabbar, Sadia
Ullah, Asmat
机构
[1] Sheikh Zayed Med Coll, Gastroenterol, Rahim Yar Khan, Pakistan
来源
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2021年 / 15卷 / 09期
关键词
MELD; Hepatocellular Carcinoma; Mortality; Cirrhosis; WAITING TIME; MODEL; MORTALITY; HEPATECTOMY; MORBIDITY; SURVIVAL; SURGERY;
D O I
10.53350/pjmhs211592841
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the frequency of high MELD score in cirrhotic patients undergoing liver resection due to hepatocellular carcinoma also compare the frequency of mortality in patients with high or low MELD score. Study Design: Cross sectional study Place and Duration: Department of Gastroenterology, Shaikh Zayed Hospital, Lahore. Duration: 6months i.e. 23 12-2017 to 22-06-2018. Methodology: 75 patients were enrolled. Then blood sample was obtained. Reports assessed and MELD score calculated. Scores were labeled as high or low. Patients underwent liver resection according to BCLC. The mortality was noted. All the collected data was entered and analyzed on SPSS version 22. Results: In this study out of total 75 cases 60 were males and 15 females. The mean age of patients was 39.44 +/- 9.76 years, male to female ratio was 4:1. Low MELD class was noted in 45 (60%) cases and high MELD class noted in 30(40%) cases. Mortality occurred in 27(36%) cases. Insignificant difference found between the MELD class with mortality. Conclusion: High MELD score was seen in 40% cirrhotic patients undergoing liver resection due to HCC. Post HCC resection, mortality occurred in 36% patients within three months of surgery. No significant association was found between the mortality and MELD score.
引用
收藏
页码:2841 / 2843
页数:3
相关论文
共 17 条
[1]   SURVIVAL AND TUMOR RELAPSE RATE ACCORDING TO ALPHAFETOPROTEIN LEVEL IN PATIENTS SUBMITTED TO LIVER TRANSPLANTATION [J].
Ataide, Elaine Cristina ;
Machado, Ricardo Rossetto ;
Capsy Ribeiro, Maxwel Boga ;
Almeida Prado Matosinho, Thiago Jose ;
Romani, Fernando Araujo ;
Fazzio Escanhonela, Cecilia Amelia ;
Santana Ferreira Boin, Ilka de Fatima .
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2011, 24 (01) :43-47
[2]   The safety of intra-abdominal surgery in patients with cirrhosis [J].
Befeler, AS ;
Palmer, DE ;
Hoffman, M ;
Longo, W ;
Solomon, H ;
Di Bisceglie, AM .
ARCHIVES OF SURGERY, 2005, 140 (07) :650-654
[3]   Waiting Time and Explant Pathology in Transplant Recipients With Hepatocellular Carcinoma: A Novel Study Using National Data [J].
Bittermann, T. ;
Hoteit, M. A. ;
Abt, P. L. ;
Forde, K. A. ;
Goldberg, D. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (07) :1657-1663
[4]   Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma [J].
Delis, Spiros G. ;
Bakoyiannis, Andreas ;
Biliatis, Ioannis ;
Athanassiou, Konstantinos ;
Tassopoulos, Nikos ;
Dervenis, Christos .
HPB, 2009, 11 (04) :351-357
[5]  
Freitas ACT, 2010, ARG GASTROENTEROL, V47, P233
[6]  
Friedman Lawrence S, 2010, Trans Am Clin Climatol Assoc, V121, P192
[7]   Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma [J].
Goldberg, David ;
French, Benjamin ;
Abt, Peter ;
Feng, Sandy ;
Cameron, Andrew M. .
LIVER TRANSPLANTATION, 2012, 18 (04) :434-443
[8]   Model for end-stage liver disease score versus Child score in predicting the outcome of surgical procedures in patients with cirrhosis [J].
Hoteit, Maarouf A. ;
Ghazale, Amaar H. ;
Bain, Andrew J. ;
Rosenberg, Eli S. ;
Easley, Kirk A. ;
Anania, Frank A. ;
Rutherford, Robin E. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (11) :1774-1780
[9]  
LOPES-JUNIOR Ascêncio Garcia, 2014, ABCD, arq. bras. cir. dig., V27, P47, DOI 10.1590/s0102-67202014000100012
[10]   A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts [J].
Malinchoc, M ;
Kamath, PS ;
Gordon, FD ;
Peine, CJ ;
Rank, J ;
ter Borg, PCJ .
HEPATOLOGY, 2000, 31 (04) :864-871